These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
111 related items for PubMed ID: 10836716
41. Beta-blockers reduce aortic stiffness in hypertension but nebivolol, not atenolol, reduces wave reflection. Mahmud A, Feely J. Am J Hypertens; 2008 Jun; 21(6):663-7. PubMed ID: 18437130 [Abstract] [Full Text] [Related]
42. TGF-beta 1 induces proliferation in human renal fibroblasts via induction of basic fibroblast growth factor (FGF-2). Strutz F, Zeisberg M, Renziehausen A, Raschke B, Becker V, van Kooten C, Müller G. Kidney Int; 2001 Feb; 59(2):579-92. PubMed ID: 11168939 [Abstract] [Full Text] [Related]
43. A vitamin D3 analog induces a G1-phase arrest in CaCo-2 cells by inhibiting cdk2 and cdk6: roles of cyclin E, p21Waf1, and p27Kip1. Scaglione-Sewell BA, Bissonnette M, Skarosi S, Abraham C, Brasitus TA. Endocrinology; 2000 Nov; 141(11):3931-9. PubMed ID: 11089522 [Abstract] [Full Text] [Related]
44. Involvement of p27Kip1 in G1 arrest by high dose 5 alpha-dihydrotestosterone in LNCaP human prostate cancer cells. Tsihlias J, Zhang W, Bhattacharya N, Flanagan M, Klotz L, Slingerland J. Oncogene; 2000 Feb 03; 19(5):670-9. PubMed ID: 10698512 [Abstract] [Full Text] [Related]
45. Identification of cdk2 binding sites on the p27Kip1 cyclin-dependent kinase inhibitor. Kwon TK, Nordin AA. Oncogene; 1998 Feb 12; 16(6):755-62. PubMed ID: 9488039 [Abstract] [Full Text] [Related]
46. TGF beta-induced growth inhibition in primary fibroblasts requires the retinoblastoma protein. Herrera RE, Mäkelä TP, Weinberg RA. Mol Biol Cell; 1996 Sep 12; 7(9):1335-42. PubMed ID: 8885230 [Abstract] [Full Text] [Related]
47. Lovastatin mediated G1 arrest in normal and tumor breast cells is through inhibition of CDK2 activity and redistribution of p21 and p27, independent of p53. Rao S, Lowe M, Herliczek TW, Keyomarsi K. Oncogene; 1998 Nov 05; 17(18):2393-402. PubMed ID: 9811471 [Abstract] [Full Text] [Related]
48. Inhibition of vascular smooth muscle cell proliferation by sodium salicylate mediated by upregulation of p21(Waf1) and p27(Kip1). Marra DE, Simoncini T, Liao JK. Circulation; 2000 Oct 24; 102(17):2124-30. PubMed ID: 11044431 [Abstract] [Full Text] [Related]
50. Cell cycle and transcriptional control of human myeloid leukemic cells by transforming growth factor beta. Hu X, Zuckerman KS. Leuk Lymphoma; 2000 Jul 17; 38(3-4):235-46. PubMed ID: 10830731 [Abstract] [Full Text] [Related]
51. Effects of oncogenic ErbB2 on G1 cell cycle regulators in breast tumour cells. Neve RM, Sutterlüty H, Pullen N, Lane HA, Daly JM, Krek W, Hynes NE. Oncogene; 2000 Mar 23; 19(13):1647-56. PubMed ID: 10763821 [Abstract] [Full Text] [Related]
52. Inhibition of the melanoma cell cycle and regulation at the G1/S transition by 12-O-tetradecanoylphorbol-13-acetate (TPA) by modulation of CDK2 activity. Coppock DL, Buffolino P, Kopman C, Nathanson L. Exp Cell Res; 1995 Nov 23; 221(1):92-102. PubMed ID: 7589260 [Abstract] [Full Text] [Related]
53. Inhibition of cyclin-dependent kinases 2 and 4 activities as well as induction of Cdk inhibitors p21 and p27 during growth arrest of human breast carcinoma cells by (-)-epigallocatechin-3-gallate. Liang YC, Lin-Shiau SY, Chen CF, Lin JK. J Cell Biochem; 1999 Oct 01; 75(1):1-12. PubMed ID: 10462699 [Abstract] [Full Text] [Related]
54. Molecular mechanisms underlying interferon-alpha-induced G0/G1 arrest: CKI-mediated regulation of G1 Cdk-complexes and activation of pocket proteins. Sangfelt O, Erickson S, Castro J, Heiden T, Gustafsson A, Einhorn S, Grandér D. Oncogene; 1999 May 06; 18(18):2798-810. PubMed ID: 10362250 [Abstract] [Full Text] [Related]
55. Induction of G1 phase arrest in MCF human breast cancer cells by pentagalloylglucose through the down-regulation of CDK4 and CDK2 activities and up-regulation of the CDK inhibitors p27(Kip) and p21(Cip). Chen WJ, Chang CY, Lin JK. Biochem Pharmacol; 2003 Jun 01; 65(11):1777-85. PubMed ID: 12781329 [Abstract] [Full Text] [Related]
56. Involvement of p27Kip1 in the G1- and S/G2-phase lengthening mediated by glucocorticoids in normal human lymphocytes. Baghdassarian N, Peiretti A, Devaux E, Bryon PA, Ffrench M. Cell Growth Differ; 1999 Jun 01; 10(6):405-12. PubMed ID: 10392902 [Abstract] [Full Text] [Related]
57. ERK pathway mediates the activation of Cdk2 in IGF-1-induced proliferation of human osteosarcoma MG-63 cells. Zhang W, Lee JC, Kumar S, Gowen M. J Bone Miner Res; 1999 Apr 01; 14(4):528-35. PubMed ID: 10234573 [Abstract] [Full Text] [Related]
58. Downregulation of cyclin-dependent kinase 2 activity and cyclin A promoter activity in vascular smooth muscle cells by p27(KIP1), an inhibitor of neointima formation in the rat carotid artery. Chen D, Krasinski K, Sylvester A, Chen J, Nisen PD, Andrés V. J Clin Invest; 1997 May 15; 99(10):2334-41. PubMed ID: 9153274 [Abstract] [Full Text] [Related]
59. A novel function of adenovirus E1A is required to overcome growth arrest by the CDK2 inhibitor p27(Kip1). Alevizopoulos K, Catarin B, Vlach J, Amati B. EMBO J; 1998 Oct 15; 17(20):5987-97. PubMed ID: 9774342 [Abstract] [Full Text] [Related]
60. Progression of LNCaP prostate tumor cells during androgen deprivation: hormone-independent growth, repression of proliferation by androgen, and role for p27Kip1 in androgen-induced cell cycle arrest. Kokontis JM, Hay N, Liao S. Mol Endocrinol; 1998 Jul 15; 12(7):941-53. PubMed ID: 9658399 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]